U.S. markets closed

ICU Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors with losses are encouraged to contact the firm to discuss their legal claims

LOS ANGELES, May 15, 2020 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ICU Medical, Inc. (ICUI) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com.

On May 8, 2020, ICU announced that the Company was "voluntarily recalling one single lot of Lactated Ringer's Injection, USP," advising that "[t]he products are being recalled to the hospital/user level due to the presence of particulate matter identified as iron oxide" and cautioning that "[a]dministration of a drug product that contains metal particulate matter could result in adverse events ranging from inflammation at the site of injection to more serious events that could include the formation of a blood clot obstructing the flow of blood which could lead to end-organ damage or death."

On this news, ICU's stock price fell $19.26 per share, or 8.86%, to close at $198.10 per share on May 8, 2020.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

BH_BH_BH_BH_BH_BH_BH_BH

Attorney Advertising